Paradigm Capital Management Inc. NY Grows Stake in Orthofix Medical Inc. (NASDAQ:OFIX)

Paradigm Capital Management Inc. NY increased its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 31.3% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,556,100 shares of the medical device company’s stock after purchasing an additional 609,137 shares during the quarter. Orthofix Medical accounts for 1.5% of Paradigm Capital Management Inc. NY’s investment portfolio, making the stock its 19th biggest holding. Paradigm Capital Management Inc. NY owned approximately 6.81% of Orthofix Medical worth $33,894,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its position in shares of Orthofix Medical by 3.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 32,957 shares of the medical device company’s stock worth $479,000 after buying an additional 1,236 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Orthofix Medical by 25.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company’s stock valued at $125,000 after purchasing an additional 1,919 shares in the last quarter. nVerses Capital LLC purchased a new stake in shares of Orthofix Medical in the second quarter valued at about $27,000. State Board of Administration of Florida Retirement System grew its position in shares of Orthofix Medical by 34.7% in the first quarter. State Board of Administration of Florida Retirement System now owns 13,562 shares of the medical device company’s stock valued at $197,000 after purchasing an additional 3,490 shares during the last quarter. Finally, Gabelli Funds LLC lifted its stake in Orthofix Medical by 3.3% in the 4th quarter. Gabelli Funds LLC now owns 139,500 shares of the medical device company’s stock valued at $1,880,000 after buying an additional 4,500 shares in the last quarter. 89.76% of the stock is currently owned by hedge funds and other institutional investors.

Orthofix Medical Price Performance

Shares of NASDAQ:OFIX opened at $15.91 on Tuesday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.13 and a current ratio of 2.48. The business’s fifty day moving average price is $16.43 and its two-hundred day moving average price is $14.74. The stock has a market cap of $597.09 million, a PE ratio of -4.71 and a beta of 1.05. Orthofix Medical Inc. has a one year low of $9.57 and a one year high of $17.67.

Orthofix Medical (NASDAQ:OFIX) last posted its quarterly earnings data on Tuesday, August 6th. The medical device company reported ($0.88) EPS for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.58). Orthofix Medical had a negative net margin of 15.61% and a negative return on equity of 20.68%. The company had revenue of $198.62 million for the quarter, compared to analyst estimates of $195.75 million. On average, analysts forecast that Orthofix Medical Inc. will post -2.13 EPS for the current fiscal year.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.